|
Kane, John P; Malloy, Mary J (2012) Prebeta-1 HDL and coronary heart disease. Curr Opin Lipidol 23:367-71
|
|
Guey, Lin T; Pullinger, Clive R; Ishida, Brian Y et al. (2011) Relation of increased prebeta-1 high-density lipoprotein levels to risk of coronary heart disease. Am J Cardiol 108:360-6
|
|
Engler, Mary B; Pullinger, Clive R; Malloy, Mary J et al. (2008) Genetic variation in phospholipid transfer protein modulates lipoprotein profiles in hyperalphalipoproteinemia. Metabolism 57:1719-24
|
|
Wung, Shu-Fen; Kulkarni, Medha V; Pullinger, Clive R et al. (2006) The lipoprotein lipase gene in combined hyperlipidemia: evidence of a protective allele depletion. Lipids Health Dis 5:19
|
|
Aouizerat, Bradley E; Engler, Mary B; Natanzon, Yanina et al. (2006) Genetic variation of PLTP modulates lipoprotein profiles in hypoalphalipoproteinemia. J Lipid Res 47:787-93
|
|
Albert, Timothy S E; Duchateau, Philippe N; Deeb, Samir S et al. (2005) Apolipoprotein L-I is positively associated with hyperglycemia and plasma triglycerides in CAD patients with low HDL. J Lipid Res 46:469-74
|
|
Wung, Shu-Fen; Aouizerat, Bradley E (2003) Gender and ethnic differences in a case-control study of dyslipidemia: using the apolipoprotein A-V gene as an exemplar in cardiovascular genetics. Res Theory Nurs Pract 17:281-99; discussion 335-8
|
|
Aouizerat, Bradley E; Kulkarni, Medha; Heilbron, David et al. (2003) Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids. J Lipid Res 44:1167-73
|
|
Pullinger, Clive R; Eng, Celeste; Salen, Gerald et al. (2002) Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest 110:109-17
|
|
Duchateau, P N; Movsesyan, I; Yamashita, S et al. (2000) Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects. J Lipid Res 41:1231-6
|
Showing the most recent 10 out of 17 publications
